^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    HBM1047

    i
    Other names: HBM1047
    Associations
    News
    Trials
    Company:
    Harbour BioMed
    Drug class:
    CD200R1 antagonist
    Related drugs:
    Associations
    News
    Trials